Research of Spinocerebellar Ataxia 30 has been linked to Aplasia, Nos, Familial Aplasia Of The Vermis, Nephronophthisis, Ataxia, Dandy-walker Syndrome. The study of Spinocerebellar Ataxia 30 has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Spinocerebellar Ataxia 30 include System Development, Nervous System Development, Cell Differentiation, Central Nervous System Development, Pathogenesis. These pathways complement our catalog of research reagents for the study of Spinocerebellar Ataxia 30 including antibodies and ELISA kits against CEP290, NPHP1, AHI1, RPGRIP1L, STRABISMUS.
Spinocerebellar Ataxia 30 Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Spinocerebellar Ataxia 30 below!
For more information on how to use Laverne, please read the How to Guide.
We have 223 products for the study of Spinocerebellar Ataxia 30 that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Spinocerebellar Ataxia 30 is also known as spinocerebellar ataxia 30, spinocerebellar ataxia type 30, sca30.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.